TY - JOUR T1 - Factors Associated with Intention to Vaccinate against COVID-19 in Puerto Rico JF - medRxiv DO - 10.1101/2021.03.19.21253972 SP - 2021.03.19.21253972 AU - Kyle Melin AU - Cheyu Zhang AU - Juan Pablo Zapata AU - Yonaira M. Rivera AU - Katie Fernandez AU - Enbal Shacham AU - Souhail M. Malavé-Rivera AU - Carlos E. Rodríguez-Díaz Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/20/2021.03.19.21253972.abstract N2 - COVID-19 has been particularly devastating to Black and Latinx communities in the U.S. However, data on acceptability of the COVID-19 vaccines among minority populations are limited. We conducted an online survey among adults in Puerto Rico to identify factors associated with intention to vaccinate against COVID-19. Sociodemographic variables were analyzed independently for association with intention to vaccinate. Significant associations were included in the multivariate logistic regression analysis. A total of 1016 responses were available for analysis. In the bivariate analysis, younger age, higher education, pre-covid employment, male sex, gay/bisexual identity, and single marital status were associated with increased intention to vaccinate. In the multivariate logistic regression, younger, male respondents who had higher educational attainment reported higher intention to vaccinate. Lower-income and living outside the San Juan metro region were associated with lower intention to vaccinate. National and international health organizations were identified as the most reliable sources of information, followed by healthcare professionals. These findings highlight the importance of considering sociodemographic characteristics identified with low intention to vaccinate as well as using trusted sources of information when designing public messaging related to increasing COVID-19 vaccinations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work of Juan Pablo Zapata was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant numbers UL1TR001436 and 1TL1TR001437. No other financial disclosures were reported by the authors of this paper.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study protocol was provided by the Human Research Subjects Protection Office at the University of Puerto Rico-Medical Sciences Campus (Protocol #A9650220).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to confidentiality agreements, supporting data can only be made available to bona fide researchers subject to a non-disclosure agreement. For details of the data and how to request access contact Dr. Carlos E. Rodriguez-Diaz, carlosrd@gwu.edu ER -